Intravenous Lidocaine for Treating Intrathecal Fentanyl Induced Pruritus
Status:
NOT_YET_RECRUITING
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The study will assess efficacy of intravenous lidocaine 1 mg/kg diluted with 0.9% sodium chloride to a volume of 100 ml to suppress intrathecal fentanyl induced pruritus. This will be compared to control group who will receive 100 ml normal saline as placebo.
The main outcome is regression of initial VAS score with incidence of pruritus.